GlassScriptPhysician profile
Zachary Jonathan Liss
NPI 1457592990
$1,278.73
in general payments reported to CMS, 2019-2025
14 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Pediatric Urology provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $18.80 · 2021: $50.00 · 2022: $24.13 · 2023: $327 · 2024: $115 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $361.66 | 2019 | |
| Neotract INC. | $157.21 | 2019-2020 | |
| Teleflex LLC | $153.27 | 2021-2023 | Urolift |
| Hologic Sales and Service, LLC | $141.55 | 2025 | Coolseal Generator |
| Myriad Genetic Laboratories, INC. | $127.83 | 2023 | Prolaris |
| Laborie Medical Technologies Corp. | $79.14 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $70.60 | 2022-2025 | Lynparza, Keytruda |
| Abbvie INC. | $50.80 | 2024-2025 | |
| Antares Pharma, INC. | $33.23 | 2021 | |
| Olympus America INC. | $22.17 | 2019 | |
| Dendreon Pharmaceuticals LLC | $21.80 | 2024 | Provenge |
| Sun Pharmaceutical Industries INC. | $20.73 | 2019 | |
| Blue Earth Diagnostics | $20.72 | 2023 | |
| 180 Medical, INC. | $18.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Liss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.